StreetInsider.com News Articles

Form SCHEDULE 13D/A Immatics N.V. Filed by: PERCEPTIVE ADVISORS LLC

Thu, 27 Aug 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260827/26989683.html

Form SCHEDULE 13D/A Immatics N.V. Filed by: PERCEPTIVE ADVISORS LLC

Thu, 27 Aug 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260827/26989683.html

Form 4 Immatics N.V. For: Aug 26 Filed by: PERCEPTIVE ADVISORS LLC

Thu, 27 Aug 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260827/26989684.html

Form 4 Immatics N.V. For: Aug 26 Filed by: PERCEPTIVE ADVISORS LLC

Thu, 27 Aug 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260827/26989684.html

Form 6-K Immatics N.V. For: Aug 26

Wed, 26 Aug 2026 17:29:00 -0400

si-local-file:///var/storage/secattach/20260826/26982983.html

Form 6-K Immatics N.V. For: Aug 26

Wed, 26 Aug 2026 17:29:00 -0400

si-local-file:///var/storage/secattach/20260826/26982983.html

Form 424B2 Immatics N.V.

Tue, 25 Aug 2026 17:30:00 -0400

si-local-file:///var/storage/secattach/20260825/26975836.html

Form 424B2 Immatics N.V.

Tue, 25 Aug 2026 17:30:00 -0400

si-local-file:///var/storage/secattach/20260825/26975836.html

Form 4 Immatics N.V. For: Aug 14 Filed by: Pepin James Nelson

Tue, 18 Aug 2026 18:02:00 -0400

si-local-file:///var/storage/secattach/20260818/26945706.html

Form 4 Immatics N.V. For: Aug 14 Filed by: Pepin James Nelson

Tue, 18 Aug 2026 18:02:00 -0400

si-local-file:///var/storage/secattach/20260818/26945706.html

Form 6-K Immatics N.V. For: Jun 30

Tue, 18 Aug 2026 07:05:00 -0400

si-local-file:///var/storage/secattach/20260818/26940443.html

Form 6-K Immatics N.V. For: Jun 30

Tue, 18 Aug 2026 07:05:00 -0400

si-local-file:///var/storage/secattach/20260818/26940443.html

Form SCHEDULE 13G/A Immatics N.V. Filed by: BAKER BROS. ADVISORS LP

Fri, 14 Aug 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260814/26929908.html

Form SCHEDULE 13G/A Immatics N.V. Filed by: BAKER BROS. ADVISORS LP

Fri, 14 Aug 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260814/26929908.html

Form 3 Immatics N.V. For: Jul 20 Filed by: Pepin James Nelson

Wed, 29 Jul 2026 16:09:00 -0400

si-local-file:///var/storage/secattach/20260729/26835025.html

Form 3 Immatics N.V. For: Jul 20 Filed by: Pepin James Nelson

Wed, 29 Jul 2026 16:09:00 -0400

si-local-file:///var/storage/secattach/20260729/26835025.html

Immatics Announces Upcoming Presentations Across Its PRAME Franchise at ESMO Congress 2026

Fri, 17 Jul 2026 10:24:00 -0400

Houston, Texas and Tuebingen, Germany, July 17, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning cell therapies and bispecifics, today announced three presentations at the European Society for Medical Oncology (ESMO) Congress 2026, to be held from October 23-27, 2026, in Madrid, Spain.

The three presentations will include:

Phase 1b data from anzu-cel, the Company’s lead PRAME cell therapy, in metastatic cutaneous and uveal melanoma, focusing on predictors of durable response
Phase 1 data from IMA203CD8

Immatics Announces Upcoming Presentations Across Its PRAME Franchise at ESMO Congress 2026

Fri, 17 Jul 2026 10:24:00 -0400

Houston, Texas and Tuebingen, Germany, July 17, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning cell therapies and bispecifics, today announced three presentations at the European Society for Medical Oncology (ESMO) Congress 2026, to be held from October 23-27, 2026, in Madrid, Spain.

The three presentations will include:

Phase 1b data from anzu-cel, the Company’s lead PRAME cell therapy, in metastatic cutaneous and uveal melanoma, focusing on predictors of durable response
Phase 1 data from IMA203CD8

Immatics Announces Upcoming Presentations Across Its PRAME Franchise at ESMO Congress 2026

Fri, 17 Jul 2026 10:24:00 -0400

Houston, Texas and Tuebingen, Germany, July 17, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning cell therapies and bispecifics, today announced three presentations at the European Society for Medical Oncology (ESMO) Congress 2026, to be held from October 23-27, 2026, in Madrid, Spain.

The three presentations will include:

Phase 1b data from anzu-cel, the Company’s lead PRAME cell therapy, in metastatic cutaneous and uveal melanoma, focusing on predictors of durable response
Phase 1 data from IMA203CD8

Immatics Announces Upcoming Presentations Across Its PRAME Franchise at ESMO Congress 2026

Fri, 17 Jul 2026 10:24:00 -0400

Houston, Texas and Tuebingen, Germany, July 17, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning cell therapies and bispecifics, today announced three presentations at the European Society for Medical Oncology (ESMO) Congress 2026, to be held from October 23-27, 2026, in Madrid, Spain.

The three presentations will include:

Phase 1b data from anzu-cel, the Company’s lead PRAME cell therapy, in metastatic cutaneous and uveal melanoma, focusing on predictors of durable response
Phase 1 data from IMA203CD8

Form S-8 Immatics N.V.

Thu, 25 Jun 2026 16:27:00 -0400
si-local-file:///var/storage/secattach/20260625/26692726.html

Form S-8 Immatics N.V.

Thu, 25 Jun 2026 16:27:00 -0400
si-local-file:///var/storage/secattach/20260625/26692726.html

Form 4 Immatics N.V. For: Jun 16 Filed by: Stone Adam Leo

Thu, 18 Jun 2026 17:16:00 -0400
si-local-file:///var/storage/secattach/20260618/26667273.html

Form 4 Immatics N.V. For: Jun 16 Filed by: Stone Adam Leo

Thu, 18 Jun 2026 17:16:00 -0400
si-local-file:///var/storage/secattach/20260618/26667273.html

Form 4 Immatics N.V. For: Jun 16 Filed by: REICIN ALISE

Thu, 18 Jun 2026 16:49:00 -0400
si-local-file:///var/storage/secattach/20260618/26666846.html